NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY CONSULTANTS UNDER THE EIDOS THERAPEUTICS, INC.Non-Qualified Stock Option Agreement • April 15th, 2019 • Eidos Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Eidos Therapeutics, Inc. 2018 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Eidos Therapeutics, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
LEASE AMENDMENT NUMBER ONELease Amendment • April 15th, 2019 • Eidos Therapeutics, Inc. • Pharmaceutical preparations
This LEASE AMENDMENT NUMBER ONE (the “Amendment”) is made on this ____27th________ day of March, 2019, by and between 101 Montgomery Street Co., a California limited partnership, (“Landlord”) and Eidos Therapeutics, Inc., a Delaware corporation (“Tenant”).
